Vivanza Biosciences Ltd. - Research Center
530057 VIVANZA Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
8.75 |
3.39 |
7.12 |
2.03 |
2.62 |
Operating profit |
0.67 |
0.16 |
- |
0.05 |
-0.04 |
Interest |
0.22 |
0.20 |
0.20 |
0.21 |
0.25 |
Gross profit |
0.51 |
0.21 |
-0.17 |
0.64 |
0.06 |
EPS (Rs) |
0.13 |
0.05 |
-0.04 |
0.16 |
0.02 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.07 |
0.25 |
0.03 |
0.80 |
0.36 |
Stock adjustment |
-0.22 |
0.57 |
-1.81 |
-0.02 |
-1.13 |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.16 |
0.13 |
0.10 |
0.02 |
0.19 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
8.14 |
2.53 |
8.83 |
1.97 |
3.61 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
- |
- |
- |
- |
- |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
0.51 |
0.21 |
-0.17 |
0.64 |
0.06 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
4.00 |
4.00 |
4.00 |
4.00 |
4.00 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
7.63 |
4.66 |
-0.04 |
2.54 |
-1.68 |
GPM (%) |
5.84 |
5.71 |
-2.35 |
22.61 |
2.18 |
NPM (%) |
5.82 |
5.68 |
-2.41 |
22.49 |
2.08 |